Aublé Law had the pleasure of assisting MyVariations in a Flex LBO alongside GENEO Capital Entrepreneur.
This strategic partnership, backed by GENEO's community of entrepreneurs, marks a new stage in MyVariations' ambition to become the European leader in oral health. The company has a virtuous business model based on the user, quality, innovation and decarbonization.
Our warmest thanks to Alexis and Martin Thiebaut and their teams for their confidence throughout this operation.
Aublé Law (Matthieu Aublé, Nathan Joder, Ombeline Madranges) advised MyVariations, alongside the PDGB team (Roy Arakelian, Guillaume Maitre), counsel to GENEO.
We also salute the role played by Scalene Partners (Samuel Assaraf, Simon Eischen, David Rocher, Grégoire Lecarpentier) in the success of this project.
